Effects of topically administered neuroprotective drugs in early stages of diabetic retinopathy: Results of the EUROCONDOR clinical trial

Autor: Simo, Rafael, Hernandez, Cristina, Porta, Massimo, Bandello, Francesco, Grauslund, Jakob, Harding, Simon P, Aldington, Stephen J, Egan, Catherine, Frydkjaer-Olsen, Ulrik, Garcia-Arumi, Jose, Gibson, Jonathan, Lang, Gabriele E, Lattanzio, Rosangela, Massin, Pascale, Midena, Edoardo, Ponsati, Berta, Ribeiro, Luisa, Scanlon, Peter, Lobo, Conceicao, Costa, Miguel Angelo, Cunha-Vaz, Jose, Garcia-Ramirez, M, van Reck, E, Gil, E, Morillas, M, Cunha-Vaz, J, Ribeiro, L, Lobo, C, Costa, MA, Nunes, S, Figueira, J, Pereira-Marques, I, Neves, C, Schwartz, C, Porta, M, Trento, M, Durando, O, Merlo, S, Bandello, F, Lattanzio, R, Zucchiatti, I, Grauslund, J, Frydkjaer-Olsen, U, Harding, SP, Scanlon, P, Aldington, SJ, Jones, V, Johnson, L, Carter, S, Spurway, J, Egan, C, Esposti, S, Leitch-Devlin, L, Rocco, V, Rees, A, Garcia-Arumi, J, Zapata, MA, Boixadera, A, Macia, C, Distefano, L, Torrent, T, Casals, F, de Dios, N, Gibson, J, Lang, GE, Jens-Ulrich, W, Christian, E, Adnan, K, Massin, P, Erginay, A, Midena, E, Vujosevic, S, Pilotto, E, Longhin, E, Convento, E, Ponsati, B, Fernandez-Carneado, J, Arrastia-Casado, S, Orgue, S, Ramirez-Lamelas, DT, Almazan-Moga, A, Salva, A, Riera, L, Treatme, European Consortium Early

Publikováno v: Simó, R, Hernández, C, Porta, M, Bandello, F, Grauslund, J, Harding, S P, Aldington, S J, Egan, C, Frydkjaer-Olsen, U, García-Arumí, J, Gibson, J, Lang, G E, Lattanzio, R, Massin, P, Midena, E, Ponsati, B, Ribeiro, L, Scanlon, P, Lobo, C, Costa, M Â, Cunha-Vaz, J & European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) 2019, ' Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy. Results of the EUROCONDOR Clinical Trial ', Diabetes, vol. 68, no. 2, pp. 457-463 . https://doi.org/10.2337/db18-0682
DIABETES

The primary objective of this study was to assess whether the topical administration of two neuroprotective drugs (brimonidine and somatostatin) could prevent or arrest retinal neurodysfunction in patients with type 2 diabetes. For this purpose, adul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1575fdf8833bf6dfe56383306a0025af

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)

Autor: Kohner, EM, Stratton, IM, Aldington, SJ, Holman, RR, Matthews, DR

AIM: to establish the degree to which the severity of retinopathy determines the risk for the need for subsequent photocoagulation in those with newly diagnosed Type 2 diabetes mellitus. METHODS: Of 5102 patients entered into the UK Prospective Diabe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::66d16ff64dd2753b8ee0ba02c6d055cf
https://doi.org/10.1046/j.1464-5491.2001.00458.x

Nine-year status of diabetic retinopathy and photocoagulation in the UK prospective diabetes study

Autor: Aldington, SJ, Stratton, IM, Holman, RR, Matthews, DR, Turner, RC, Kohner, EM

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9286fcdcec3dc97c8ac81f84f5ef7a2a
https://ora.ox.ac.uk/objects/uuid:351ca6b6-53c6-4ddb-9244-d7863e76ec1c

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.